Glytec empowers hospitals and health systems to deliver safer, smarter, and more efficient glycemic care—at scale.
Trusted by over 400 hospitals nationwide, Glytec’s enterprise insulin management platform supports both frontline clinicians and executive decision-makers in achieving meaningful improvements in patient outcomes, staff efficiency, and financial performance.
At the heart of Glytec’s platform is Glucommander®, the first FDA-cleared, cloud-based insulin dosing software. Built to support IV and subcutaneous insulin therapy across the continuum of care, Glucommander personalizes dosing using real-time and historical patient data to optimize safety and effectiveness. It seamlessly integrates into EHR workflows, reduces time to target, and streamlines management of conditions such as DKA and HHS. Hospitals using Glucommander have reported a 99.8% reduction in severe hypoglycemia, shorter lengths of stay, and significant reductions in readmissions and cost of care.
Complementing Glucommander is Command Center, Glytec’s AI-powered executive intelligence platform. Designed for CEOs, CMOs, and CFOs, Command Center converts EMR and glycemic data into actionable insights for system-wide risk surveillance, performance benchmarking, and CMS eCQM readiness. Executives can quickly identify high-risk discharges, detect underperforming units, and prioritize interventions that reduce ICU escalations and financial penalties.
Together, Glytec’s solutions deliver aligned value across the organization—from bedside care to boardroom strategy. Whether your goal is to meet evolving quality benchmarks or enhance system-wide operational efficiency, Glytec provides the tools to lead with confidence and precision.
For additional information, visit www.glytec.com, follow Glytec on LinkedIn, or contact:
Debbie Dean
Chief Government & Strategy Officer
(404) 932-8117
ddean@glytec.com
Glytec
100 Cambridge Street
14th Floor
Boston, MA 02114
(864) 370-3297
info@glytec.com